Glenmark Life Sciences posts Q3 FY23 PAT at Rs. 104.99 Cr
News

Glenmark Life Sciences posts Q3 FY23 PAT at Rs. 104.99 Cr

The company has reported total income of Rs. 547.33 crores during the period ended December 31, 2022

  • By IPP Bureau | January 29, 2023

Glenmark Life Sciences Ltd has posted net profit of Rs. 104.99 crores for the period ended December 31, 2022 as against net profit of Rs. 106.87 crores for the period ended September 30, 2022. The company posted net profit of Rs.103.71 crores for the period ended December 31, 2021.

The company has reported total income of Rs. 547.33 crores during the period ended December 31, 2022 as compared to Rs. 519.31 crores during the period ended September 30, 2022. It reported total income of Rs.526.03 crores during the period ended December 31, 2021.

For the Financial Year December 31, 2022, Glenmark Life Sciences has reported total income of Rs.1566.02 crores as compared to Rs.1618.76 crores during the 9-month period ended December 31, 2021.

The company has posted net profit of Rs.320.60 crores for the 9-month period ended December 31, 2022 as against net profit of Rs.319.82 crores for the 9-month period ended December 31, 2021.

Upcoming E-conference

Other Related stories

Startup

Digitization